Filing Details

Accession Number:
0001209191-20-063655
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-12-15 20:49:19
Reporting Period:
2020-12-11
Accepted Time:
2020-12-15 20:49:19
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1020214 Cerus Corp CERS Surgical & Medical Instruments & Apparatus (3841) 680262011
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1564252 Chrystal Menard C/O Cerus Corporation
1220 Concord Ave Suite 600
Concord CA 94520
Chief Legal Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2020-12-11 4,167 $4.33 52,742 No 4 M Direct
Common Stock Disposition 2020-12-11 4,167 $8.00 48,585 No 4 S Direct
Common Stock Acquisiton 2020-12-11 3,959 $4.32 52,544 No 4 M Direct
Common Stock Disposition 2020-12-11 3,959 $8.00 48,585 No 4 S Direct
Common Stock Acquisiton 2020-12-11 11,362 $4.46 59,947 No 4 M Direct
Common Stock Disposition 2020-12-11 11,362 $8.00 48,585 No 4 S Direct
Common Stock Acquisiton 2020-12-11 21,875 $4.46 70,460 No 4 M Direct
Common Stock Disposition 2020-12-11 21,875 $8.00 48,585 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Option (Right to Buy) Disposition 2020-12-11 4,167 $0.00 4,167 $4.33
Common Stock Option (Right to Buy) Disposition 2020-12-11 3,959 $0.00 3,959 $4.32
Common Stock Option (Right to Buy) Disposition 2020-12-11 11,362 $0.00 11,362 $4.46
Common Stock Option (Right to Buy) Disposition 2020-12-11 21,875 $0.00 21,875 $4.46
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
95,833 2027-02-28 No 4 M Direct
91,041 2028-02-28 No 4 M Direct
68,516 2025-03-01 No 4 M Direct
0 2025-03-01 No 4 M Direct
Footnotes
  1. This transaction was executed pursuant to a 10b5-1 plan.
  2. One eighth (1/8th) of the shares subject to the Option vested six (6) months after the grant date, and one forty-eighth (1/48th) of the shares subject to the Option vested each month thereafter.
  3. Not applicable.